25 research outputs found

    Distribution of systolic and diastolic blood pressure at baseline.

    No full text
    <p>The distribution of SBP and DBP are presented for the total population and stratified by ESA use. The total percentage of patients within the blood pressure target (DBP: 80 mmHg and SBP: 130 mmHg) are depicted in the histogram. Abbreviations: ESA = Erythropoiesis-Stimulating Agent, SBP = Systolic Blood Pressure, DBP = Diastolic Blood Pressure.</p

    Difference in antihypertensive drugs and BP in patients with and without ESA.

    No full text
    <p>Values are presented as mean difference in number of antihypertensive drugs or difference in blood pressure (with 95% Confidence Interval).</p><p><sup>1</sup> Adjusted for age and sex.</p><p><sup>2</sup> Adjusted for age, sex, BMI, Diabetes Mellitus, Cardiovascular disease, eGFR.</p><p>Abbreviations: ESA = Erythropoiesis-Stimulating Agent, SBP = Systolic Blood Pressure, DBP = Diastolic Blood pressure, ref = Reference, BMI = Body Mass Index, eGFR = estimated Glomerular Filtration Rate.</p

    Characteristics of patients with and without ESA at the start of pre-dialysis care.

    No full text
    <p>Values are presented as mean (standard deviation) or percentage.</p><p>Abbreviations: ESA = Erythropoiesis-Stimulating Agent, BMI = Body Mass Index, eGFR = estimated Glomerular Filtration Rate.</p

    Time course of hepato-splanchnic hemodynamics.

    No full text
    <p>Time course of splanchnic vascular resistance index (<i>RI</i>) (top panel) and hepato-splanchnic perfusion index (<i>QI</i>) (bottom panel) measured at times <i>t</i><sub>1</sub> through <i>t</i><sub>4</sub> during dialysis in diabetic (red symbols) and non-diabetic (green symbols) subjects. Symbols represent average values ± standard deviations of duplicate measurements obtained in treatments separated by one week. For clarity, symbols for diabetics and non-diabetics are placed with a small left or right offset from the actual measuring times.</p

    Scheme of hepato-splanchinc contribution for hemodynamic stability.

    No full text
    <p>Splanchnic vasoconstriction reduces arterial inflow (black arrows) thereby lowering downstream distending pressures and mobilizing blood volume (white arrows) sequestered in the compliant splanchnic vasculature. At the same time reduced portal vein flow draining form splanchnic vascular beds (purple) causes a compensatory increase (red arrow) in the separate hepatic arterial blood flow (red) because of compensatory vasodilation in Mall´s space.</p

    Hepato-splanchnic perfusion and resistance.

    No full text
    <p>Splanchnic perfusion index (<i>QI</i>) as function of hepato-splanchnic resistance index (<i>RI</i>) (top panel) and hepato-splachnic vascular conductance (bottom panel), respectively, during hemodialysis, in diabetic (red symbols) and non-diabetic (green symbols) subjects. Broken lines indicate the best fit of <i>QI</i> to <i>RI</i> (top panel, <i>y</i> = 6.71/<i>x</i>, <i>r</i><sup>2</sup> = 0.77) and 1/<i>RI</i> (bottom panel, <i>y</i> = 0.02+6.54<i>x</i>, <i>r</i><sup>2</sup> = 0.77), respectively.</p
    corecore